Juan Luis Carrillo Linares

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Placebo Controlled

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Belén Murcia Casas, Juan Luis Carrillo Linares, Isabel Baquero Aranda, José Rioja, Vicente Merino-Bohórquez, Andrés González Jiménez, Miguel Ángel Rico Corral, Ricardo Bosch, Miguel Ángel Sánchez Chaparro, María Inmaculada García-Fernández, Pedro Valdivielso
Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial. International journal of molecular sciences 24 (5) (2023)
Belén Murcia Casas, Juan Luis Carrillo Linares, Isabel Baquero Aranda, José Rioja, Vicente Merino-Bohórquez, Andrés González Jiménez, Miguel Ángel Rico Corral, Ricardo Bosch, Miguel Ángel Sánchez Chaparro, María Inmaculada García-Fernández, Pedro Valdivielso
Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial. International journal of molecular sciences 24 (5) (2023)
Belén Murcia Casas, Juan Luis Carrillo Linares, Isabel Baquero Aranda, José Rioja, Vicente Merino-Bohórquez, Andrés González Jiménez, Miguel Ángel Rico Corral, Ricardo Bosch, Miguel Ángel Sánchez Chaparro, María Inmaculada García-Fernández, Pedro Valdivielso
Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial. International journal of molecular sciences 24 (5) (2023)
Belén Murcia Casas, Juan Luis Carrillo Linares, Isabel Baquero Aranda, José Rioja, Vicente Merino-Bohórquez, Andrés González Jiménez, Miguel Ángel Rico Corral, Ricardo Bosch, Miguel Ángel Sánchez Chaparro, María Inmaculada García-Fernández, Pedro Valdivielso
Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial. International journal of molecular sciences 24 (5) (2023)